MYLK and inflammatory bowel disease: lncRNA Growth Arrest Specific 5 or GAS5 display connection with glucocorticoid responses in pediatric IBD (Lucafò et al., 2018) (Table 1) and CCAT1 or Colon Cancer-associated Transcript 1 promotes IBD-induced malignancy by enhancing myosin light chain kinase (MLCK) activity and downregulating miR-185-3p (Ma et al., 2019) (Table 1).